Sorafenib is a kinase inhibitor drug approved for the treatment of primary kidney
cancer (advanced renal cell carcinoma), advanced primary liver cancer ...
Aug 15, 2016 ... Sorafenib is used to treat advanced renal cell carcinoma (RCC; a type of cancer
that begins in the kidneys). Sorafenib is also used to treat ...
Apr 29, 2015 ... Read about the cancer treatment drug sorafenib, otherwise known as Nexavar,
including what it is, how it works and possible side effects.
Nov 26, 2013 ... On November 22, 2013, the Food and Drug Administration (FDA) approved
sorafenib tosylate (Nexavar<sup>®</sup> tablets, made by Bayer Healthcare ...
Jun 13, 2005 ... Sorafenib (rINN), marketed as Nexavar by Bayer, is a drug approved for the
treatment of advanced renal cell carcinoma (primary kidney cancer) ...
Learn about Nexavar (Sorafenib) may treat, uses, dosage, side effects, drug
interactions, warnings, patient labeling, reviews, and related medications.
Find patient medical information for sorafenib oral on WebMD including its uses,
side effects and safety, interactions, pictures, warnings and user ratings.
Sorafenib is a synthetic compound targeting growth signaling and angiogenesis.
Sorafenib blocks the enzyme RAF kinase, a critical component of the ...
Sorafenib (Nexavar) is an orally active multikinase inhibitor that is approved in
the EU for the treatment of hepatocellular carcinoma. Monotherapy with sorafenib
Easy to read patient leaflet for sorafenib. Includes indications, proper use, special
instructions, precautions, and possible side effects.